Skip to main content
Latest news
Browse specialties
Breast cancer Genitourinary cancers Lung & thoracic cancers
In focus
Next-generation sequencing: Emerging biomarkers in thyroid and NSCLCs ctDNA and bladder cancer: Current understanding and beyond ROS1 fusion-positive NSCLC NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC Early-stage NSCLC management: Surgery, targeted treatment and immunotherapy ALK fusion-positive NSCLC: International approaches to management RET fusion-positive NSCLC: Informing on the use of pralsetinib for patients with RET fusion-positive, advanced NSCLC COVID-19 & cancer
Conferences
SABCS 2022 ESMO 2022 2022 ASCO Annual Meeting
About us
Medicine Matters Oncology
EXTENDED SEARCH

Medicine Matters oncology

Seoul National University Hospital, South Korea


Professor Bang, Professor of Medical Oncology, is the President of Biomedical Research Institute and Director of the Clinical Trials Center of Seoul National University Hospital.

He has been working for Seoul National University College of Medicine and Hospital since 1986. He has served many positions including Director of the Cancer Research Institute, Chairman of Department of Internal Medicine, and Chairman of the Korean Cancer Association.

Professor Bang has co-authored more than 400 papers in SCI-indexed journals including The New England Journal of Medicine and The Lancet. He is primarily interested in phase I trials and gastric cancer trials. He is the principal investigator of a number of international gastric cancer trials including ToGA, CLASSIC, SHINE, GOLD, and JAVELIN Gastric 300.